161 related articles for article (PubMed ID: 17898046)
21. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.
Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M
Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640
[TBL] [Abstract][Full Text] [Related]
22. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.
Eckhart L; Raffelsberger W; Ferko B; Klima A; Purtscher M; Katinger H; Rüker F
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2001-8. PubMed ID: 8810996
[TBL] [Abstract][Full Text] [Related]
23. F(ab')2 fragment of a gp41 NHR-trimer-induced IgM monoclonal antibody neutralizes HIV-1 infection and blocks viral fusion by targeting the conserved gp41 pocket.
Lu L; Wei M; Chen Y; Xiong W; Yu F; Qi Z; Jiang S; Pan C
Microbes Infect; 2013 Nov; 15(13):887-94. PubMed ID: 24141089
[TBL] [Abstract][Full Text] [Related]
24. Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity.
Louis JM; Bewley CA; Clore GM
J Biol Chem; 2001 Aug; 276(31):29485-9. PubMed ID: 11418583
[TBL] [Abstract][Full Text] [Related]
25. Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
McLain L; Brown JL; Cheung L; Reading SA; Parry C; Jones TD; Cleveland SM; Dimmock NJ
Arch Virol; 2001; 146(1):157-66. PubMed ID: 11266210
[TBL] [Abstract][Full Text] [Related]
26. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
Blish CA; Nguyen MA; Overbaugh J
PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
[TBL] [Abstract][Full Text] [Related]
27. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
[TBL] [Abstract][Full Text] [Related]
28. ELDKWA-epitope-specific monoclonal antibodies inhibit HIV env-mediated syncytium formation.
Zhang G; Chen YH
Immunobiology; 2003; 207(4):259-64. PubMed ID: 12952348
[TBL] [Abstract][Full Text] [Related]
29. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.
Zhang MY; Choudhry V; Sidorov IA; Tenev V; Vu BK; Choudhary A; Lu H; Stiegler GM; Katinger HW; Jiang S; Broder CC; Dimitrov DS
J Immunol Methods; 2006 Dec; 317(1-2):21-30. PubMed ID: 17078964
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
[TBL] [Abstract][Full Text] [Related]
31. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.
Lopalco L; Longhi R; Ciccomascolo F; De Rossi A; Pelagi M; Andronico F; Moore JP; Schulz T; Beretta A; Siccardi AG
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):33-9. PubMed ID: 7678970
[TBL] [Abstract][Full Text] [Related]
32. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
[TBL] [Abstract][Full Text] [Related]
33. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.
Vella C; Ferguson M; Dunn G; Meloen R; Langedijk H; Evans D; Minor PD
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2603-7. PubMed ID: 7506299
[TBL] [Abstract][Full Text] [Related]
34. Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5.
Kunert RE; Weik R; Ferko B; Stiegler G; Katinger H
AIDS; 2002 Mar; 16(4):667-8. PubMed ID: 11873012
[TBL] [Abstract][Full Text] [Related]
35. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
Zwick MB; Komori HK; Stanfield RL; Church S; Wang M; Parren PW; Kunert R; Katinger H; Wilson IA; Burton DR
J Virol; 2004 Mar; 78(6):3155-61. PubMed ID: 14990736
[TBL] [Abstract][Full Text] [Related]
36. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
Sánchez-Martínez S; Lorizate M; Hermann K; Kunert R; Basañez G; Nieva JL
FEBS Lett; 2006 Apr; 580(9):2395-99. PubMed ID: 16616522
[TBL] [Abstract][Full Text] [Related]
37. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
Cleveland SM; McLain L; Cheung L; Jones TD; Hollier M; Dimmock NJ
J Gen Virol; 2003 Mar; 84(Pt 3):591-602. PubMed ID: 12604810
[TBL] [Abstract][Full Text] [Related]
38. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope.
Fiebig U; Schmolke M; Eschricht M; Kurth R; Denner J
AIDS; 2009 May; 23(8):887-95. PubMed ID: 19414989
[TBL] [Abstract][Full Text] [Related]
39. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
Pastori C; Barassi C; Piconi S; Longhi R; Villa ML; Siccardi AG; Clerici M; Lopalco L
J Biol Regul Homeost Agents; 2000; 14(1):15-21. PubMed ID: 10763886
[TBL] [Abstract][Full Text] [Related]
40. Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.
Zhou M; Meyer T; Koch S; Koch J; von Briesen H; Benito JM; Soriano V; Haberl A; Bickel M; Dübel S; Hust M; Dietrich U
Eur J Immunol; 2013 Feb; 43(2):499-509. PubMed ID: 23180650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
